SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:lup.lub.lu.se:fda422e9-4a40-4511-baea-ca7e32c9e711"
 

Sökning: onr:"swepub:oai:lup.lub.lu.se:fda422e9-4a40-4511-baea-ca7e32c9e711" > Proteomic analysis ...

Proteomic analysis of brain metastatic lung adenocarcinoma reveals intertumoral heterogeneity and specific alterations associated with the timing of brain metastases

Woldmar, N. (författare)
Lund University,Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Federal University of Rio de Janeiro
Schwendenwein, A. (författare)
Medical University of Vienna
Kuras, M. (författare)
Lund University,Lunds universitet,Klinisk kemi, Malmö,Forskargrupper vid Lunds universitet,Clinical Protein Science and Imaging,Clinical Chemistry, Malmö,Lund University Research Groups
visa fler...
Szeitz, B. (författare)
Semmelweis University
Boettiger, K. (författare)
Medical University of Vienna
Tisza, A. (författare)
Semmelweis University,National Korányi Institute for Tuberculosis and Pulmonology, Hungary
László, V. (författare)
National Korányi Institute for Tuberculosis and Pulmonology, Hungary,Medical University of Vienna
Reiniger, L. (författare)
Semmelweis University,Hungarian Academy of Sciences
Bagó, A. G. (författare)
Szállási, Z. (författare)
Hungarian Academy of Sciences,Danish Cancer Society,Harvard Medical School
Moldvay, J. (författare)
Hungarian Academy of Sciences,National Korányi Institute for Tuberculosis and Pulmonology, Hungary
Szász, A. M. (författare)
Semmelweis University,National Korányi Institute for Tuberculosis and Pulmonology, Hungary
Malm, J. (författare)
Lund University,Lunds universitet,Klinisk kemi, Malmö,Forskargrupper vid Lunds universitet,Clinical Chemistry, Malmö,Lund University Research Groups,Skåne University Hospital
Horvatovich, P. (författare)
University of Groningen
Pizzatti, L. (författare)
Federal University of Rio de Janeiro
Domont, G. B. (författare)
Federal University of Rio de Janeiro
Rényi-Vámos, F. (författare)
National Institute of Oncology, Budapest,National Korányi Institute for Tuberculosis and Pulmonology, Hungary,Semmelweis University
Hoetzenecker, K. (författare)
Medical University of Vienna
Hoda, M. A. (författare)
Medical University of Vienna
Marko-Varga, G. (författare)
Lund University,Lunds universitet,Avdelningen för Biomedicinsk teknik,Institutionen för biomedicinsk teknik,Institutioner vid LTH,Lunds Tekniska Högskola,Department of Biomedical Engineering,Departments at LTH,Faculty of Engineering, LTH
Schelch, K. (författare)
Medical University of Vienna
Megyesfalvi, Z. (författare)
National Korányi Institute for Tuberculosis and Pulmonology, Hungary,National Institute of Oncology, Budapest,Semmelweis University,Medical University of Vienna
Rezeli, M. (författare)
Lund University,Lunds universitet,Avdelningen för Biomedicinsk teknik,Institutionen för biomedicinsk teknik,Institutioner vid LTH,Lunds Tekniska Högskola,Department of Biomedical Engineering,Departments at LTH,Faculty of Engineering, LTH
Döme, B. (författare)
National Institute of Oncology, Budapest,Lund University,Skåne University Hospital,Medical University of Vienna,National Korányi Institute for Tuberculosis and Pulmonology, Hungary,Semmelweis University
visa färre...
 (creator_code:org_t)
Elsevier BV, 2023
2023
Engelska.
Ingår i: ESMO Open. - : Elsevier BV. - 2059-7029. ; 8:1
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Background: Brain metastases are associated with considerable negative effects on patients’ outcome in lung adenocarcinoma (LADC). Here, we investigated the proteomic landscape of primary LADCs and their corresponding brain metastases. Materials and methods: Proteomic profiling was conducted on 20 surgically resected primary and brain metastatic LADC samples via label-free shotgun proteomics. After sample processing, peptides were analyzed using an Ultimate 3000 pump coupled to a QExactive HF-X mass spectrometer. Raw data were searched using PD 2.4. Further data analyses were carried out using Perseus, RStudio and GraphPad Prism. Proteomic data were correlated with clinical and histopathological parameters and the timing of brain metastases. Mass spectrometry-based proteomic data are available via ProteomeXchange with identifier PXD027259. Results: Out of the 6821 proteins identified and quantified, 1496 proteins were differentially expressed between primary LADCs and corresponding brain metastases. Pathways associated with the immune system, cell-cell/matrix interactions and migration were predominantly activated in the primary tumors, whereas pathways related to metabolism, translation or vesicle formation were overrepresented in the metastatic tumors. When comparing fast- versus slow-progressing patients, we found 454 and 298 differentially expressed proteins in the primary tumors and brain metastases, respectively. Metabolic reprogramming and ribosomal activity were prominently up-regulated in the fast-progressing patients (versus slow-progressing individuals), whereas expression of cell-cell interaction- and immune system-related pathways was reduced in these patients and in those with multiple brain metastases. Conclusions: This is the first comprehensive proteomic analysis of paired primary tumors and brain metastases of LADC patients. Our data suggest a malfunction of cellular attachment and an increase in ribosomal activity in LADC tissue, promoting brain metastasis. The current study provides insights into the biology of LADC brain metastases and, moreover, might contribute to the development of personalized follow-up strategies in LADC.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Nyckelord

brain metastasis
clinical proteomics
intertumoral heterogeneity
lung adenocarcinoma

Publikations- och innehållstyp

art (ämneskategori)
ref (ämneskategori)

Hitta via bibliotek

  • ESMO Open (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy